Trial Profile
A Phase III, Open-Label, Multicentre Study to Evaluate Efficacy, Pharmacokinetics, and Safety of Biostate in Paediatric Subjects With Haemophilia A
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Factor VIII/von Willebrand factor (Primary)
- Indications Haemophilia A
- Focus Pharmacokinetics; Therapeutic Use
- Sponsors CSL Behring
- 10 Nov 2014 New trial record